• The long-term safety of this drug on the heart and also blood vessels (cardiovascular) is not known.
• It is not known whether taking medicine helps improve how well you take your antiretroviral medications and also
• It is not known if this medicine is safe and effective in children, so do not use it in children.

DOSAGE AND ADMINISTRATION

The recommended dose of EGRIFTA™ is 2 mg injected subcutaneously once a day.

The recommended injection site is the abdomen. Injection sites should be rotated to different areas of the abdomen. So, do not inject into scar tissue, bruises, or the navel.

EGRIFTA™ must be reconstituted with the diluent provided with the product.

Reconstitute the 2 mg vial of EGRIFTA™ with 2.1 mL of diluent. Mix by rolling the vial gently in your hands for 30 seconds. Do not shake.

Detailed instructions for reconstituting EGRIFTA™ are provided in the INSTRUCTIONS FOR USE leaflet enclosed in the boxes containing EGRIFTA™ and diluent.

Administer EGRIFTA™ immediately the following reconstitution and throw away any unused EGRIFTA™ solution. If not used immediately, the reconstituted EGRIFTA™ solution should be discarded. Do not freeze or refrigerate the reconstituted EGRIFTA™ solution.

Buy more products related to HGH and Steroids from our store.